Crossmark

Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?

Crossref DOI link: https://doi.org/10.1016/j.nefroe.2024.06.003

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alonso, Marta http://orcid.org/0000-0001-8270-9037
Villanego, Florentino http://orcid.org/0000-0002-7828-9479
Vigara, Luis Alberto http://orcid.org/0000-0001-6568-6160
Rodríguez, María Eugenia

Eady, Myriam

García, Ana

Mínguez, María Carmen

Montero, María Elisa

Segurado, Oscar

García, Teresa http://orcid.org/0000-0002-2491-3221
Mazuecos, Auxiliadora http://orcid.org/0000-0002-5860-2309
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-06-12
More Information

This article is maintained by: Elsevier

Article Title: Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?

Journal Title: Nefrología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefroe.2024.06.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nefro.2023.06.007

Content Type: simple-article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología.

Document is current

Any future updates will be listed below